“Incidence and Factors Associated With Adverse Drug Reactions in a Cohort of Individuals Starting Dolutegravir or Efavirenz ”. Research, Society and Development 11, no. 4 (March 28, 2022): e0811426250. Accessed December 5, 2025. https://rsdjournal.org/rsd/article/view/26250.